Scynexis (SCYX) Current Deferred Revenue (2013 - 2026)
Scynexis (SCYX) reported Current Deferred Revenue of $235000.0 for Q1 2026, down 91.9% on a YoY basis from $2.9 million in Q1 2025, and little changed quarter-over-quarter from $235000.0 in Q4 2025.
Scynexis (SCYX) Current Deferred Revenue (2013 - 2026) Analysis & Trends
Scynexis has reported Current Deferred Revenue for 11 years, with the latest figure at $235000.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Deferred Revenue fell 91.9% year-over-year to $235000.0; the trailing twelve-month figure through Mar 2026 stood at $235000.0 (down 91.9% YoY), and the FY2025 full-year result was $235000.0, down 85.69% from the prior year.
- Current Deferred Revenue for Q1 2026 stood at $235000.0, roughly flat from $235000.0 in the prior quarter.
- The five-year high for Current Deferred Revenue was $3.2 million in Q2 2023, with the low at $235000.0 in Q4 2025.
- Historically, Current Deferred Revenue has averaged $1.7 million across 4 years, with a median of $1.6 million in 2024.
- Annual changes were most pronounced in 2025 — Current Deferred Revenue soared 163.64% — and 2026, when it sank 91.9%.
- Scynexis' Current Deferred Revenue stood at $1.2 million in 2023, then soared by 38.1% to $1.6 million in 2024, then plunged by 85.69% to $235000.0 in 2025, then changed by 0.0% to $235000.0 in 2026.
- The last three Current Deferred Revenue figures came in at $235000.0 (Q1 2026), $235000.0 (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Scynexis | 225.23 Mn | 165.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 235,000.00 |
| Dec 31, 2025 | 235,000.00 |
| Sep 30, 2025 | 1.77 Mn |
| Jun 30, 2025 | 2.30 Mn |
| Mar 31, 2025 | 2.90 Mn |
| Dec 31, 2024 | 1.64 Mn |
| Sep 30, 2024 | 1.64 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | 1.19 Mn |
| Sep 30, 2023 | 2.44 Mn |
| Jun 30, 2023 | 3.20 Mn |
| Mar 31, 2019 | 54,000.00 |
| Dec 31, 2018 | 121,000.00 |
| Sep 30, 2018 | 185,000.00 |
| Jun 30, 2018 | 249,000.00 |
| Mar 31, 2018 | 257,000.00 |
| Dec 31, 2017 | 257,000.00 |
| Sep 30, 2017 | 257,000.00 |
| Jun 30, 2017 | 257,000.00 |